DENVER, Oct. 24, 2019 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Tuesday, November 5, 2019, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.
This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows:
Tuesday, November 5, 2019
Starting at 5:00 p.m. EST
Dial in number: 877-918-6630
International dial in: 517-308-9042
Webcast: investors.davita.com
When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen to the conference call will be able to access a replay via our website at investors.davita.com. There will be no telephone replay.
About DaVita Inc.
DaVita (DVA) is a Fortune 500® health care provider focused on transforming care delivery to improve quality of life for patients around the globe. The company is the largest provider of kidney care services in the U.S. and has been a leader in clinical quality and innovation for 20 years. Through DaVita Kidney Care, the company treats patients with chronic kidney failure and end stage renal disease. DaVita is committed to bold, patient-centric care models, implementing the latest technologies and moving toward integrated care offerings for all. As of June 30, 2019, DaVita served 204,900 patients at 2,723 outpatient dialysis centers in the United States. The company also operated 248 outpatient dialysis centers in nine countries across the world. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more about how DaVita is leading the health care evolution, please, visit DaVita.com/About.
Contact Information
Investors:
Jim Gustafson
(310) 536-2585
[email protected]
SOURCE DaVita Inc.
![](https://rt.prnewswire.com/rt.gif?NewsItemId=LA14724&Transmission_Id=201910240642PR_NEWS_USPR_____LA14724&DateId=20191024)
Share this article